SEARCH

SEARCH BY CITATION

References

  • 1
    McColl E, Meadows K, Barofsky I. Cognitive aspects of survey methodology and quality of life assessment. Qual Life Res 2003;12:21718.
  • 2
    Acquadro C, Berzon R, Dubois D, et al. Incorporating the patient's perspective into drug development and communication: an Ad Hoc Task Force report on the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003;5: 52231.
  • 3
    Sullivan M. The new subjective medicine: taking the patient's point of view on health care and health. Soc Sci Med 2003;56:1595604.
  • 4
    American Psychological Association and the National Council on Measurement in Education. Standards for Educational and Psychological Testing. Prepared by the American Educational Research Association, 2002.
  • 5
    Nunnally JC, Bernstein IH. Psychometric Theory (3rd ed.). New York: McGraw-Hill, 1994.
  • 6
    Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Rockville, MD: Food and Drug Administration, 2006.
  • 7
    Lohr K, for the Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193205.
  • 8
    Ferrans CE. Definitions and conceptual models of quality of life. In: LipscombJ, GotayCC, SnyderC, eds. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
  • 9
    Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:1926.
  • 10
    Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997;278:4750.
  • 11
    Erickson P. Assessing health status and quality of life of cancer patients: the use of general instruments. In: LipscombJ, GotayCC, SnyderC, eds. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
  • 12
    Darby C. Measuring the patient's perspective on the interpersonal aspects of cancer care. In: LipscombJ, GotayCC, SnyderC, eds. Outcomes Assessment in Cancer. Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
  • 13
    Gustafson DH. Needs assessment in cancer. In:LipscombJ, GotayCC, SnyderC, eds. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
  • 14
    Burke LB. The patient voice in medical product evaluation: FDA draft guidance on measuring patient-reported outcomes. Presented at the Third Plenary Session of the Biannual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, May 24, 2006.
  • 15
    Fayers PM, Hand DJ. Factor analysis, causal indicators and quality of life. Quality Life Res 1997;6:13950.
  • 16
    Fayers PM, Hand DJ. Causal variables, indicator variables and measurement scales: an example from quality of life. J Royal Stat Soc––Series A 2002;165:23361.
  • 17
    Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996;18:97992.
  • 18
    Scott JA. Using patient-reported outcome (PRO) instruments to measure study endpoints. Presented at the QOL Assessment in Symptom Management Trials Workshop, sponsored by the National Cancer Institute Community Clinical Oncology Program, Rockville, MD, October 24–25, 2005.
  • 19
    Cleeland CS, Nakamura Y, Mendoza TR, et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 1996;67:26773.
  • 20
    Wilson IB, Cleary PD. Linking clinical variables and health-related quality of life: a conceptual model of patient outcomes. JAMA 1995;273:5965.
  • 21
    Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncology 2001;12(Suppl. 3):S36.
  • 22
    Hays RD, Revicki D, Coyne KS. Application of structural equation modeling for health outcomes research. Eval Health Prof 2005;28:295309.